|
|
Article: Trade Alert for Neurocrine Biosciences Inc.
- Article from:
- M2 Presswire
- Article date:
- March 23, 2007
CopyrightCOPYRIGHT 2007 M2 Communications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-23 March 2007-Biotech News: Trade Alert for Neurocrine Biosciences Inc(C)1994-2007 M2 COMMUNICATIONS LTD
RDATE:23032007
Trade Alert for Neurocrine Biosciences Inc (NASDAQ:NBIX)
Neurocrine Biosciences, Inc. engages in the discovery and development of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. It primarily develops drugs for the treatment of insomnia, anxiety, depression, various female and male health disorders, multiple sclerosis, diabetes, and other neurological and endocrine related diseases and disorders. The company�s primary clinical development program, ...